B. Morales

Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15)

P. Angus, P. Gow, J. George, 2018, Alimentary pharmacology & therapeutics.

Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers.

S. Tan, S. Lim, W. Sukeepaisarnjaroen, 2015, World journal of gastroenterology.